When we analyzed the relationship between resistin and fascin-1 expression, we found a significantly higher level of fascin-1 expression in CRC tissue specimens from cases that were strongly positive for resistin (50.0%, 27/54) compared with those that were not strongly resistin-positive (34.6%, 62/179; P < 0.05, Table 3) (Figure 2). The gene discussed is RETN; the disease is colorectal carcinoma.